Michael Brush

Cannabis stocks are down sharply ever since the group got its best news in decades – President Donald Trump’s December 18 executive order to reschedule the plant. Using the AdvisorShares Pure U.S. Cannabis exchange-traded fund (MSOS) as a proxy, the group... See more

Since the effective federal hemp-derived THC ban was approved in the latest budget deal, cannabis investors are in meltdown mode. They are acting like the change is a sign the Trump administration is no longer serious about rescheduling – the main catalys... See more

Like most retailers, cannabis companies report late in the earnings season. So the sector just finished reporting the third quarter. Here are the four key sector insights from earnings calls – three positive and one negative. 1. Rescheduling Remains Likel... See more

Warren Buffett famously loves companies with moats. The presence of protective moats around his holdings is one of the main reasons he’s outperformed over the years. Moats are relatively easy to recognize and understand, compared to the more complex quali... See more

While President Donald Trump hangs fire on rescheduling cannabis, we continue to get signs that support what I believe is the inexorable march towards greater acceptance of cannabis use and legal reform that will help public companies in the space. We see... See more